Sonja Nelson Ambrx Biopharma Inc. (AMAM) insider trading activity
Sonja Nelson is Chief Financial Officer of Ambrx Biopharma Inc.. Currently has a direct ownership of 1 Million shares of AMAM, which is worth approximately $28 Million. The most recent transaction as insider was on Apr 26, 2023, when has been sold 1,000,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1M
0%
3M change
0%
12M change
Total Value Held
$28 Million
Sonja Nelson Transaction History
Also insider at
SN
Sonja Nelson
Chief Financial Officer
San Diego, CA